Quality and sustainability go hand in hand in keeping with our commitment to transparency and continuous improvement within our GMP (Good Manufacturing Practice) Facility – from farm production, science, manufacturing, distribution, security and product delivery to local and global markets.
“Current New Zealand numbers estimate 160,000+ patients are using cannabis as a medicine.”
Oncologist Dr Anthony Falkar states that between 40-60% of his patients are using this product obtained via the black market.
It is our belief and responsibility that everybody who works within the Med Green Pharmaceutical framework does so in a fair, safe, nondiscriminatory and empowering environment. Our people and their wellness are our reason for being.
It's the illicit drug one in three have used in their lifetime, but could lighting up a joint soon be... read more →September 26, 2018